Kerrisdale Advisers, LLC Kaleido Biosciences, Inc. Transaction History

Kerrisdale Advisers, LLC

  • $264 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$5.02 - $8.87 $363,849 - $642,897
-72,480 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$11.25 - $18.1 $1,125 - $1,810
-100 Reduced 0.14%
72,480 $841,000
Q1 2019

May 15, 2019
BUY
$12.71 - $15.0 $922,491 - $1.09 Million
72,580 New
72,580 $1.05 Million

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Kerrisdale Advisers, LLC Portfolio

Follow Kerrisdale Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerrisdale Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerrisdale Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email